In most neuroendocrine tumours, the expression of SSTR subtypes at the tumour site is associated with an SST-mediated antitumour role, supporting the role of SST as an endogenous inhibitor of cell proliferation [44]. The gene discussed is SST; the disease is neuroendocrine neoplasm.